Skip to main content
Log in

Methodische Schwächen und Fehler bei der Datenextraktion führen zu einer erheblichen Unterschätzung der Sterblichkeit bei Sepsis und septischem Schock in Deutschland

Methodological weaknesses and errors in the data extraction lead to a substantial underestimation of the mortality of sepsis and septic shock in Germany

  • Leserbriefe
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

This article has been updated

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Change history

  • 28 July 2021

    In der Box „Weitere Artikel zu diesem Beitrag“ wurde der Link zu den Leserbriefen korrigiert.

Literatur

  1. Bauer M, Groesdonk HV, Preissing F, Dickmann P, Vogelmann T, Gerlach H (2021) [Mortality in sepsis and septic shock in Germany. Results of a systematic review and meta-analysis]. Der Anaesthesist. 2021

  2. Fleischmann-Struzek C, Mikolajetz A, Schwarzkopf D, Cohen J, Hartog C, Pletz M et al (2018) Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between national health systems—secular trends in sepsis and infection incidence and mortality in Germany. Intensive Care Med 44(11):1826–1835

    Article  CAS  Google Scholar 

  3. Scheer CS, Fuchs C, Kuhn SO, Vollmer M, Rehberg S, Friesecke S et al (2017) Quality improvement initiative for severe sepsis and septic shock reduces 90-day mortality: a 7.5-year observational study. Crit Care Med 45(2):241–252

    Article  Google Scholar 

  4. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S et al (2007) Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33(4):606–618

    Article  Google Scholar 

  5. SepNet Critical Care Trials Group (2016) Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 42(12):1980–1989

    Article  Google Scholar 

  6. Fleischmann C, Thomas-Rueddel DO, Hartmann M, Hartog CS, Welte T, Heublein S et al (2016) Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 113(10):159–166

    PubMed  PubMed Central  Google Scholar 

  7. Schmidt K, Gensichen J, Fleischmann-Struzek C, Bahr V, Pausch C, Sakr Y et al (2020) Long-term survival following sepsis. Dtsch Arztebl Int 117(46):775–782

    PubMed  PubMed Central  Google Scholar 

  8. Bloos F, Thomas-Ruddel D, Ruddel H, Engel C, Schwarzkopf D, Marshall JC et al (2014) Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 18(2):R42

    Article  Google Scholar 

  9. Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U et al (2016) Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial. JAMA Intern Med 176(9):1266–1276

    Article  Google Scholar 

  10. Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N et al (2017) The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial. PloS one 12(10):e0187015

    Article  Google Scholar 

  11. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M et al (2014) Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care 18(5):507

    Article  Google Scholar 

  12. Bloos F, Ruddel H, Thomas-Ruddel D, Schwarzkopf D, Pausch C, Harbarth S et al (2017). Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial. Intensive care medicine 43(11):1602–1612

    Article  Google Scholar 

  13. Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C et al (2012) Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA : the journal of the American Medical Association 307(22):2390–2399

    Article  CAS  Google Scholar 

  14. Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D (2020) Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019—results from a systematic review and meta-analysis. Crit Care 24(1):239

    Article  Google Scholar 

  15. Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS et al (2017) Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 376(23):2235–2244

    Article  Google Scholar 

  16. Kahn JM, Davis BS, Yabes JG, Chang CCH, Chong DH, Hershey TB et al (2019) Association between state-mandated protocolized sepsis care and in-hospital mortality among adults with sepsis. JAMA 322(3):240–250

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konrad Reinhart.

Ethics declarations

Interessenkonflikt

K. Reinhart hält Aktien der Inflarx AG NV aus Jena.

Additional information

In der Box „Weitere Artikel zu diesem Beitrag“ wurde der Link zu den Leserbriefen korrigiert.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reinhart, K. Methodische Schwächen und Fehler bei der Datenextraktion führen zu einer erheblichen Unterschätzung der Sterblichkeit bei Sepsis und septischem Schock in Deutschland. Anaesthesist 70, 683–685 (2021). https://doi.org/10.1007/s00101-021-00988-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-021-00988-7

Navigation